Journal list menu
Export Citations
Download PDFs
ISSUE INFORMATION
ORIGINAL ARTICLE
Open Access
oa
Hormone Therapy Usage Is Associated With Adverse Cardiovascular Events in Prostate Cancer Patients of the All of Us Research Program Cohort
- Pages: 1077-1086
- First Published: 11 June 2025
Open Access
oa
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN Guidelines
- Pages: 1087-1095
- First Published: 22 May 2025
Open Access
oa
A Multimarker Model for Prostate Cancer Risk Assessment: Improving Diagnostic Accuracy Beyond PSA
- Pages: 1096-1103
- First Published: 26 May 2025
Open Access
oa
Role of Cell-Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2-ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
- Pages: 1104-1113
- First Published: 29 May 2025
Open Access
oa
Genomic Signatures Correlating With Adverse Pathologic Features in Men Eligible for Active Surveillance
- Pages: 1114-1120
- First Published: 20 June 2025
Open Access
oa
Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
- Pages: 1121-1133
- First Published: 12 June 2025
Open Access
oa
Comprehensive Genomic Profiling Testing for Castration-Resistant Prostate Cancer in Advanced Elderly Patients: A Single-Center Retrospective Cohort Study
- Pages: 1134-1142
- First Published: 10 June 2025
no
History of Vasectomy Is not Associated With Prostate Cancer Progression in Men on Active Surveillance
- Pages: 1143-1150
- First Published: 23 June 2025
RAPID COMMUNICATION
Open Access
oa
Real-World Overall Survival Comparison of Enzalutamide and Abiraterone In First- and Second-Line Setting of Metastatic Castration-Resistant Prostate Cancer
- Pages: 1151-1154
- First Published: 08 June 2025
LETTER TO THE EDITOR
no
SBRT Boost in Prostate Cancer: Progress Made, Questions Remain
- Pages: 1155-1156
- First Published: 26 May 2025